Previous Close | 4.23 |
1-Year Change | -73.66% |
6-Months Change | -56.88% |
3-Months Change | -21.23% |
Moving Avg (50d) | 5.1396 |
Moving Avg (200d) | 9.2545 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 153.1M |
Beta (3-Years) | 1.56 |
Revenue Growth (ttm) | 6.97% |
Net Profit Margin (ttm) | -24.22% |
Return On Assets (ttm) | -18.24% |
EPS (ttm) | -2.87 |
PE Ratio (ttm) | -1.47 |
Dividend Yield | % |
Asset Description: | Nevro Corp. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-10-30 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
4.43 | 4.294 | 4.204 | 4.068 | 3.842 | 3.616 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |